Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class ...

Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type 2 diabetes (T2D), have ...

The WEGOVY market has experienced significant growth, driven by rising obesity rates and increasing demand for effective weight-loss treatments. Novo Nordisk's blockbuster drug has seen strong ...

GLP-1 receptor agonists are transforming obesity treatment, but manufacturing challenges must be addressed to meet rising ...

Figure 1: Control ... of the mutant peptide but do not prove nor refute dominance for the mutant allele. Figure 2: Distribution of hypocretin-containing cells in the human hypothalamus.

Beyond type 2 diabetes and weight loss, GLP-1 agonists can also help lower blood pressure, improve lipid disorders, reduce ...

Many peptide medications like glucagon-like peptide-1 (GLP-1) receptor agonists were initially developed to treat type 2 diabetes. One unexpected side effect of these drugs is weight loss.

On Wednesday, Clone Robotics released video footage of its Protoclone humanoid robot, a full-body machine that uses synthetic muscles to create unsettlingly human-like movements. In the video ...

Kendrick Lamar's performance of "Not Like Us" at the 2025 Super Bowl halftime show has sent the song to the No. 1 spot on the Billboard Hot 100 yet again. The song debuted at No. 1 in its first ...